Search research articles
Contact Us
Filters
Showing results (301-310 of 1,358) with videos related to
Page
of 136
Sort By:
Experientia
|
July 15, 1994
Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside
M H Ravindranath, S M Brazeau, D L Morton
Cancer Research
|
August 1, 1978
Antigens on human tumor cells assayed by complement fixation with allogeneic sera
R K Gupta, R F Irie, D L Morton
Journal of Surgical Oncology
|
July 1, 1984
Failure of subcutaneous mastectomy to prevent the development of breast cancer
J E Goodnight, J M Quagliana, D L Morton
Journal of the National Cancer Institute
|
April 1, 1978
Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients
D O Chee, E C Holmes, D L Morton
Journal of Surgical Oncology
|
January 1, 1980
Production and characterization of xenogeneic antisera to tumor-associated antigen(s)
R K Gupta, H K Silver, D L Morton
JAMA
|
June 9, 1975
Immunotherapy of malignancy in humans. Current status
E C Holmes, F R Eilber, D L Morton
Cancer Research
|
December 1, 1974
Differential effects of rifampicin on cultured human tumor cells
W D Winters, A L Tuan, D L Morton
Molecular & General Genetics : MGG
|
September 28, 1998
Downstream elements from the pea albumin 1 gene confer sulfur responsiveness on a reporter gene
R L Morton, A J Ellery, T J Higgins
Surgery, Gynecology & Obstetrics
|
July 1, 1979
Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion
F K Storm, F C Sparks, D L Morton
Cancer Research
|
February 1, 1973
Delayed cutaneous hypersensitivity to cell-free tumor antigens
E C Holmes, R A Reisfeld, D L Morton
Page
of 136
Search research articles
Search
Showing results (301-310 of 1,358) with videos related to
Sort By:
Page
of 136
Experientia
|
July 15, 1994
Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside
M H Ravindranath, S M Brazeau, D L Morton
Cancer Research
|
August 1, 1978
Antigens on human tumor cells assayed by complement fixation with allogeneic sera
R K Gupta, R F Irie, D L Morton
Journal of Surgical Oncology
|
July 1, 1984
Failure of subcutaneous mastectomy to prevent the development of breast cancer
J E Goodnight, J M Quagliana, D L Morton
Journal of the National Cancer Institute
|
April 1, 1978
Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients
D O Chee, E C Holmes, D L Morton
Journal of Surgical Oncology
|
January 1, 1980
Production and characterization of xenogeneic antisera to tumor-associated antigen(s)
R K Gupta, H K Silver, D L Morton
JAMA
|
June 9, 1975
Immunotherapy of malignancy in humans. Current status
E C Holmes, F R Eilber, D L Morton
Cancer Research
|
December 1, 1974
Differential effects of rifampicin on cultured human tumor cells
W D Winters, A L Tuan, D L Morton
Molecular & General Genetics : MGG
|
September 28, 1998
Downstream elements from the pea albumin 1 gene confer sulfur responsiveness on a reporter gene
R L Morton, A J Ellery, T J Higgins
Surgery, Gynecology & Obstetrics
|
July 1, 1979
Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion
F K Storm, F C Sparks, D L Morton
Cancer Research
|
February 1, 1973
Delayed cutaneous hypersensitivity to cell-free tumor antigens
E C Holmes, R A Reisfeld, D L Morton
Page
of 136